European Radiology:使用氧提取分数(OEF)评价子痫前期患者深部灰质的脑氧代谢变化

2022-08-06 shaosai MedSci原创

氧提取分数(OEF)是脑组织活力和功能的一个重要指标,利用平扫MRI绘制其图谱具有很大的临床意义。

包括慢性高血压、妊娠期高血压和先兆子痫(PE)高血压疾病影响着全世界多达10%的孕妇,是孕产妇死亡的六大原因之一,占所有孕产妇死亡的近10%。

PE患者有多种神经系统症状,与系统性血管损伤、内皮功能紊乱以及随之而来的低灌注和缺氧有关。然而,目前还没有一种方法可以直接测量孕妇大脑中的氧代谢情况。诊断PE最常用的方法是经颅多普勒超声(TCD),但由于TCD只能用于评估大动脉,无法反映脑内微循环的变化。磁共振成像(MRI)可以获得形态学和生理学信息。最近,体外非相干运动(IVIM)已被用于评估PE患者的灌注分数和水肿。IVIM可以估计毛细血管水平的血液灌注,但不能直接反映大脑的氧代谢。因此,迫切需要找到一个精确而敏感的神经影像学标志物来直接评估PE患者的脑氧代谢情况。

氧提取分数(OEF)是脑组织活力和功能的一个重要指标,利用平扫MRI绘制其图谱具有很大的临床意义。QSM和基于血氧水平的量化幅度(QSM + qBOLD = QQ)的OEF图谱是一种新的MRI技术,能够无创地量化脑氧代谢。

近日,发表在European Radiology杂志的一项研究比较了先兆子痫患者、健康孕妇和非怀孕育龄妇女的深层灰质(GM)的OEF值,探讨了他们在GM中的脑氧代谢差异,为临床早期识别潜在的中枢神经系统损伤,并进行有针对性的治疗以减少PE和随之而来子痫并发症的发生提供了参考依据。

本研究纳入47名PE患者、40名NPHCs和21名PHCs。脑部OEF值由QSM和基于定量血氧水平的幅度(QSM + qBOLD = QQ)图谱计算得出。采用单因素方差分析来比较三组的平均OEF值。使用接ROC曲线分析估计每个感兴趣区域的平均OEF值的曲线下面积。 

本研究发现,丘脑、壳核、尾状核、苍白球和黑质的平均OEF值在这三组中有明显差异(F=5.867,p=0.004;F=5.142,p=0007;F=6.158,p=0.003;F=6.319,p=0.003;F=5.491,p=0.005)。这5个区域的平均OEF值在PE患者中高于NPHCs和PHCs(P < 0.05)。这些ROI的AUC从0.673到0.692(p < 0.01),截断值从35.1到36.6%不等,表明OEF值可以区分PE患者和非PE患者。逐步多变量分析显示,OEF值与孕妇的血细胞比容相关(r = 0.353,p = 0.003)。 


图 来自NPHC、PHC和PE的代表性T1w、OEF、QSM maps。T1w和QSM maps可以准确识别解剖结构。丘脑、壳核、尾状核、苍白球和黑质的平均OEF值在三组中明显不同。与NPHC和PHC相比,PE患者的平均OEF值更高,但NPHC和PHC之间的平均OEF值没有统计学上的显著差异。NPHC,34岁;PHC,33岁,35孕周;PE,30岁,33孕周

本研究发现,与PHCs和NPHCs相比,PE患者的丘脑、壳核、尾状核、苍白球和黑质的平均OEF值增加,这些变化可能是克服严重缺氧和维持脑氧代谢的一种补偿机制。可以使用基于QQ的无创OEF图谱来测量孕妇大脑中OEF值的明显变化,较高的平均OEF值常预示着高血压疾病的存在。

原文出处:

Linfeng Yang,Junghun Cho,Tao Chen,et al.Oxygen extraction fraction (OEF) assesses cerebral oxygen metabolism of deep gray matter in patients with pre-eclampsia.DOI:10.1007/s00330-022-08713-7

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1729703, encodeId=cc681e2970397, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed May 31 20:13:01 CST 2023, time=2023-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951972, encodeId=ddb019519e28a, content=<a href='/topic/show?id=90a1254194a' target=_blank style='color:#2F92EE;'>#代谢变化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25419, encryptionId=90a1254194a, topicName=代谢变化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Sat Jul 22 21:13:01 CST 2023, time=2023-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242152, encodeId=fdb8124215248, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62206167433, createdName=ms4000001291803254, createdTime=Tue Aug 30 22:19:13 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1366582, encodeId=40bc136658282, content=<a href='/topic/show?id=097a452219b' target=_blank style='color:#2F92EE;'>#子痫前期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45221, encryptionId=097a452219b, topicName=子痫前期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Mon Aug 08 04:13:01 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444782, encodeId=daae1444e8297, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Mon Aug 08 04:13:01 CST 2022, time=2022-08-08, status=1, ipAttribution=)]
    2023-05-31 feather89
  2. [GetPortalCommentsPageByObjectIdResponse(id=1729703, encodeId=cc681e2970397, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed May 31 20:13:01 CST 2023, time=2023-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951972, encodeId=ddb019519e28a, content=<a href='/topic/show?id=90a1254194a' target=_blank style='color:#2F92EE;'>#代谢变化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25419, encryptionId=90a1254194a, topicName=代谢变化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Sat Jul 22 21:13:01 CST 2023, time=2023-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242152, encodeId=fdb8124215248, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62206167433, createdName=ms4000001291803254, createdTime=Tue Aug 30 22:19:13 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1366582, encodeId=40bc136658282, content=<a href='/topic/show?id=097a452219b' target=_blank style='color:#2F92EE;'>#子痫前期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45221, encryptionId=097a452219b, topicName=子痫前期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Mon Aug 08 04:13:01 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444782, encodeId=daae1444e8297, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Mon Aug 08 04:13:01 CST 2022, time=2022-08-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1729703, encodeId=cc681e2970397, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed May 31 20:13:01 CST 2023, time=2023-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951972, encodeId=ddb019519e28a, content=<a href='/topic/show?id=90a1254194a' target=_blank style='color:#2F92EE;'>#代谢变化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25419, encryptionId=90a1254194a, topicName=代谢变化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Sat Jul 22 21:13:01 CST 2023, time=2023-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242152, encodeId=fdb8124215248, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62206167433, createdName=ms4000001291803254, createdTime=Tue Aug 30 22:19:13 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1366582, encodeId=40bc136658282, content=<a href='/topic/show?id=097a452219b' target=_blank style='color:#2F92EE;'>#子痫前期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45221, encryptionId=097a452219b, topicName=子痫前期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Mon Aug 08 04:13:01 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444782, encodeId=daae1444e8297, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Mon Aug 08 04:13:01 CST 2022, time=2022-08-08, status=1, ipAttribution=)]
    2022-08-30 ms4000001291803254

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1729703, encodeId=cc681e2970397, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed May 31 20:13:01 CST 2023, time=2023-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951972, encodeId=ddb019519e28a, content=<a href='/topic/show?id=90a1254194a' target=_blank style='color:#2F92EE;'>#代谢变化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25419, encryptionId=90a1254194a, topicName=代谢变化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Sat Jul 22 21:13:01 CST 2023, time=2023-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242152, encodeId=fdb8124215248, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62206167433, createdName=ms4000001291803254, createdTime=Tue Aug 30 22:19:13 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1366582, encodeId=40bc136658282, content=<a href='/topic/show?id=097a452219b' target=_blank style='color:#2F92EE;'>#子痫前期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45221, encryptionId=097a452219b, topicName=子痫前期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Mon Aug 08 04:13:01 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444782, encodeId=daae1444e8297, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Mon Aug 08 04:13:01 CST 2022, time=2022-08-08, status=1, ipAttribution=)]
    2022-08-08 yahu
  5. [GetPortalCommentsPageByObjectIdResponse(id=1729703, encodeId=cc681e2970397, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed May 31 20:13:01 CST 2023, time=2023-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951972, encodeId=ddb019519e28a, content=<a href='/topic/show?id=90a1254194a' target=_blank style='color:#2F92EE;'>#代谢变化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25419, encryptionId=90a1254194a, topicName=代谢变化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Sat Jul 22 21:13:01 CST 2023, time=2023-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242152, encodeId=fdb8124215248, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62206167433, createdName=ms4000001291803254, createdTime=Tue Aug 30 22:19:13 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1366582, encodeId=40bc136658282, content=<a href='/topic/show?id=097a452219b' target=_blank style='color:#2F92EE;'>#子痫前期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45221, encryptionId=097a452219b, topicName=子痫前期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Mon Aug 08 04:13:01 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444782, encodeId=daae1444e8297, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Mon Aug 08 04:13:01 CST 2022, time=2022-08-08, status=1, ipAttribution=)]
    2022-08-08 huagfeg

相关资讯

JAMA:低剂量“神药”阿司匹林预防子痫及相关发病率和死亡率

子痫前期是影响孕妇的最严重的健康问题之一。

Hypertension:sFlt-1/PlGF比值对子痫前期相关不良结局的预测能力

在多标记建模方法中结合生物标志物指标和所有可用信息,增加了对可疑疾病妇女不良结果的检测能力。

ATVB:妊娠和子痫前期与急性外周动脉事件有关

在考虑到估计受孕时间和预后的局限性时,妊娠尤其是合并子痫前期会增加急性外周动脉事件的风险。

AJOG:低剂量阿司匹林是否可降低高风险孕妇的子痫前期风险?

低剂量阿司匹林已经成为最研究广泛的子痫前期预防药物,它真的能降低高风险妊娠女性的子痫前期风险吗?

Circulation:降脂“神药”他汀居然还能改善子痫发作!

普拉伐他汀在高风险的子痫前期妇女中并没有减少子痫前期分娩的发生率。

JCEM:正常妊娠和子痫前期孕产妇脂肪和能量平衡的变化

与正常妊娠相比,子痫前期后的产后阶段,胰岛素抵抗和FM%增加,高密度脂蛋白降低,以及生活方式以久坐为主要特征。